...
search icon
sxtp-img

60 Degrees Pharmaceuticals, Inc. Common Stock, Common Stock

SXTP

NAQ

$2.67

-$0.49

(-15.51%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$5.08M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.86M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.41 L
$23.94 H
$2.67

About 60 Degrees Pharmaceuticals, Inc. Common Stock, Common Stock

60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for respiratory viruses and dengue. It also has patent license agreement with Tufts Medical Center to jointly advance the development and commercialization of tafenoquine for the treatment and prevention of babesiosis. The company was founded in 2010 and is headquartered in Washington, District Of Columbia. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameSXTPSectorS&P500
1-Week Return-22.61%-1.91%-4.4%
1-Month Return43.55%-8.22%-10.77%
3-Month Return-34.88%-5.01%-15.29%
6-Month Return-45.51%-10.62%-11.9%
1-Year Return-82.27%-3.17%2.9%
3-Year Return-99.05%1.04%20.61%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue2.18M1.16M223.21K253.57K607.57K[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":53.19,"profit":true},{"date":"2022-12-31","value":10.23,"profit":true},{"date":"2023-12-31","value":11.62,"profit":true},{"date":"2024-12-31","value":27.85,"profit":true}]
Cost of Revenue702.99K850.74K432.37K474.55K384.76K[{"date":"2020-12-31","value":82.63,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":50.82,"profit":true},{"date":"2023-12-31","value":55.78,"profit":true},{"date":"2024-12-31","value":45.23,"profit":true}]
Gross Profit1.48M309.60K(209.16K)(220.98K)222.81K[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":20.94,"profit":true},{"date":"2022-12-31","value":-14.15,"profit":false},{"date":"2023-12-31","value":-14.95,"profit":false},{"date":"2024-12-31","value":15.07,"profit":true}]
Gross Margin67.77%26.68%(93.71%)(87.15%)36.67%[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":39.37,"profit":true},{"date":"2022-12-31","value":-138.27,"profit":false},{"date":"2023-12-31","value":-128.58,"profit":false},{"date":"2024-12-31","value":54.11,"profit":true}]
Operating Expenses1.85M1.43M1.54M4.93M9.94M[{"date":"2020-12-31","value":18.59,"profit":true},{"date":"2021-12-31","value":14.43,"profit":true},{"date":"2022-12-31","value":15.51,"profit":true},{"date":"2023-12-31","value":49.65,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(418.13K)(1.12M)(1.75M)(5.15M)(9.71M)[{"date":"2020-12-31","value":-41813000,"profit":false},{"date":"2021-12-31","value":-112410200,"profit":false},{"date":"2022-12-31","value":-175044500,"profit":false},{"date":"2023-12-31","value":-515458300,"profit":false},{"date":"2024-12-31","value":-971493100,"profit":false}]
Total Non-Operating Income/Expense(5.31M)(6.31M)(8.42M)(2.05M)1.75M[{"date":"2020-12-31","value":-303.02,"profit":false},{"date":"2021-12-31","value":-360.12,"profit":false},{"date":"2022-12-31","value":-480.48,"profit":false},{"date":"2023-12-31","value":-116.8,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(3.05M)(4.26M)(6.18M)(3.81M)(7.96M)[{"date":"2020-12-31","value":-304747000,"profit":false},{"date":"2021-12-31","value":-425929900,"profit":false},{"date":"2022-12-31","value":-617728400,"profit":false},{"date":"2023-12-31","value":-381355000,"profit":false},{"date":"2024-12-31","value":-795541300,"profit":false}]
Income Taxes1.00K1.00K500.00250.00250.00[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":50,"profit":true},{"date":"2023-12-31","value":25,"profit":true},{"date":"2024-12-31","value":25,"profit":true}]
Income After Taxes(3.05M)(4.26M)(6.18M)(3.81M)(7.96M)[{"date":"2020-12-31","value":-304847000,"profit":false},{"date":"2021-12-31","value":-426029900,"profit":false},{"date":"2022-12-31","value":-617778400,"profit":false},{"date":"2023-12-31","value":-381380000,"profit":false},{"date":"2024-12-31","value":-795566300,"profit":false}]
Income From Continuous Operations(3.05M)(4.26M)(6.18M)(3.44M)(7.96M)[{"date":"2020-12-31","value":-304847000,"profit":false},{"date":"2021-12-31","value":-426029900,"profit":false},{"date":"2022-12-31","value":-617778400,"profit":false},{"date":"2023-12-31","value":-343723700,"profit":false},{"date":"2024-12-31","value":-795566300,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(3.03M)(4.25M)(6.18M)(3.77M)(7.95M)[{"date":"2020-12-31","value":-303374400,"profit":false},{"date":"2021-12-31","value":-425174500,"profit":false},{"date":"2022-12-31","value":-618172000,"profit":false},{"date":"2023-12-31","value":-376570200,"profit":false},{"date":"2024-12-31","value":-794710700,"profit":false}]
EPS (Diluted)---(0.69)(33.34)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-68.75,"profit":false},{"date":"2024-12-31","value":-3334.25,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

SXTP
Cash Ratio 1.00
Current Ratio 3.25
Quick Ratio 2.98

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

SXTP
ROA (LTM) -89.67%
ROE (LTM) -181.78%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

SXTP
Debt Ratio Lower is generally better. Negative is bad. 0.31
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.70

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

SXTP
Trailing PE NM
Forward PE NM
P/S (TTM) 6.83
P/B 0.00
Price/FCF NM
EV/R 20.93
EV/Ebitda 22.23

FAQs

What is 60 Degrees Pharmaceuticals, Inc. Common Stock share price today?

60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) share price today is $2.67

Can Indians buy 60 Degrees Pharmaceuticals, Inc. Common Stock shares?

Yes, Indians can buy shares of 60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) on Vested. To buy 60 Degrees Pharmaceuticals, Inc. Common Stock from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SXTP stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of 60 Degrees Pharmaceuticals, Inc. Common Stock be purchased?

Yes, you can purchase fractional shares of 60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) via the Vested app. You can start investing in 60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) with a minimum investment of $1.

How to invest in 60 Degrees Pharmaceuticals, Inc. Common Stock shares from India?

You can invest in shares of 60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) via Vested in three simple steps:

  • Click on Sign Up or Invest in SXTP stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in 60 Degrees Pharmaceuticals, Inc. Common Stock shares
What is 60 Degrees Pharmaceuticals, Inc. Common Stock 52-week high and low stock price?

The 52-week high price of 60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) is $23.94. The 52-week low price of 60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) is $1.41.

What is 60 Degrees Pharmaceuticals, Inc. Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of 60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) is 0.00

What is the Market Cap of 60 Degrees Pharmaceuticals, Inc. Common Stock?

The market capitalization of 60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) is $5.08M

What is 60 Degrees Pharmaceuticals, Inc. Common Stock’s stock symbol?

The stock symbol (or ticker) of 60 Degrees Pharmaceuticals, Inc. Common Stock is SXTP

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top